Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

Jean‐Claude Tardif; Marc A. Pfeffer; Simon Kouz; Wolfgang Köenig; Aldo Maggioni; John J.V. McMurray; Vincent Mooser; David D. Waters; Jean C. Grégoire; Philippe L. L’Allier; J. Wouter Jukema; Harvey D. White; Therèse Heinonen; Donald M. Black; Fouzia Laghrissi‐Thode; Sylvie Lévesque; Marie Claude Guertin; Marie‐Pierre Dubé

doi:10.1093/eurheartj/ehac374

Related publications

Article2025

Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib

Jean‐Claude Tardif, Marc A. Pfeffer, Simon Kouz, Wolfgang Köenig, Aldo Maggioni, John J.V. McMurray, David D. Waters, J. Wouter Jukema, Harvey D. White, Therèse Heinonen, David Kallend, Fouzia Laghrissi‐Thode, Valtteri Muroke, Annik Fortier, Marie‐Claude Guertin, Marie‐Pierre Dubé

Article2020

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

Jean‐Claude Tardif, Marie‐Pierre Dubé, Marc A. Pfeffer, David D. Waters, Wolfgang Köenig, Aldo Maggioni, John J.V. McMurray, Vincent Mooser, Harvey D. White, Therèse Heinonen, Donald M. Black, Marie‐Claude Guertin

Article2017

Plasma Renin Activity, Response to Aliskiren, and Clinical Outcomes in Patients Hospitalized for Heart Failure: The ASTRONAUT Trial

Muthiah Vaduganathan, Baljash Cheema, Erin R. Cleveland, K. Nathan Sankar, Haris Subačius, Gregg C. Fonarow, Scott D. Solomon, Eldrin F. Lewis, Stephen J. Greene, Aldo Maggioni, Michael Böhm, Faı̈ez Zannad, Javed Butler, Mihai Gheorghiade

Article2024

A Randomized Controlled Trial on the Efficacy and Safety of a Calcium-Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor in Chinese and European Patients with Hypertension

Wei Zhang, Changyuan Liu, Grzegorz Bilo, Davide Soranna, Antonella Zambon, Konstantinos G. Kyriakoulis, Αναστάσιος Κόλλιας, Isabella Ceravolo, Silvia Cassago, Martino F. Pengo, Antonios Destounis, George S. Stergiou, Ji‐Guang Wang, Gianfranco Parati

Article2022

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

Anna J. Podolanczuk, John S. Kim, Christopher B. Cooper, Joseph A. Lasky, Susan Murray, Justin M. Oldham, Ganesh Raghu, Kevin R. Flaherty, Cathie Spino, Imre Noth, Fernando J. Martínez, Elizabeth Freiheit, Adam Martin‐Schwarze, Ashley Szparza, Tanvi Naik, Rex Edwards, Gordon R. Bernard, Deborah R. Barnbaum, João A. de Andrade, Daren L. Knoell, Peter K. Lindenauer, André Rogatko, Marinella Temprosa,